Immunotherapeutics for head and neck squamous cell carcinoma stem cells

Qian, X.; Leonard, F.; Wenhao, Y.; Sudhoff, Holger; Hoffmann, T. K.; Ferrone, S.; Kaufmann, A. M.; Albers, A. E.

Immunotherapeutics for head and neck squamous cell carcinoma stem cells

Qian X, Leonard F, Wenhao Y, Sudhoff H, Hoffmann TK, Ferrone S, Kaufmann AM, Albers AE (2020)
HNO 68(2): 94-99.

Zeitschriftenaufsatz | Veröffentlicht | Englisch

Download

Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!

DOI

https://doi.org/10.1007/s00106-020-00819-y

Autor*in

Qian, X.; Leonard, F.; Wenhao, Y.; Sudhoff, Holger^UniBi ; Hoffmann, T. K.; Ferrone, S.; Kaufmann, A. M.; Albers, A. E.

Einrichtung

Medizinische Fakultät OWL > AG 202 Hals-Nasen-Ohrenheilkunde

Alternativer Titel

Immuntherapeutika gegen Kopf-Hals-Plattenepithelkarzinom-Stammzellen

Abstract / Bemerkung

Cancer stem cell (CSC)-related therapy resistance has become a new obstacle to the successful application of cancer treatment and head and neck squamous cell carcinoma (HNSCC) is no exception to this finding. Head and neck squamous cell carcinoma is highly immune-suppressive, and recently the immune suppression and invasion of HNSCC-CSCs have been characterized. These characteristics have received research and clinical attention because they would enable the stratification of patients into specific cancer subtypes and, consequently, the establishment of new therapeutic approaches with improved efficacy. This review discusses the feasibility of CSC-targeted strategies and their incorporation with nanotechnology to improve the efficacy of cancer immunotherapy.

Erscheinungsjahr

2020

Zeitschriftentitel

HNO

Band

Ausgabe

Seite(n)

94-99

ISSN

0017-6192

eISSN

1433-0458

Page URI

https://pub.uni-bielefeld.de/record/2951613

Zitieren

Qian X, Leonard F, Wenhao Y, et al. Immunotherapeutics for head and neck squamous cell carcinoma stem cells. HNO. 2020;68(2):94-99.

Qian, X., Leonard, F., Wenhao, Y., Sudhoff, H., Hoffmann, T. K., Ferrone, S., Kaufmann, A. M., et al. (2020). Immunotherapeutics for head and neck squamous cell carcinoma stem cells. HNO, 68(2), 94-99. https://doi.org/10.1007/s00106-020-00819-y

Qian, X., Leonard, F., Wenhao, Y., Sudhoff, Holger, Hoffmann, T. K., Ferrone, S., Kaufmann, A. M., and Albers, A. E. 2020. “Immunotherapeutics for head and neck squamous cell carcinoma stem cells”. HNO 68 (2): 94-99.

Qian, X., Leonard, F., Wenhao, Y., Sudhoff, H., Hoffmann, T. K., Ferrone, S., Kaufmann, A. M., and Albers, A. E. (2020). Immunotherapeutics for head and neck squamous cell carcinoma stem cells. HNO 68, 94-99.

Qian, X., et al., 2020. Immunotherapeutics for head and neck squamous cell carcinoma stem cells. HNO, 68(2), p 94-99.

X. Qian, et al., “Immunotherapeutics for head and neck squamous cell carcinoma stem cells”, HNO, vol. 68, 2020, pp. 94-99.

Qian, X., Leonard, F., Wenhao, Y., Sudhoff, H., Hoffmann, T.K., Ferrone, S., Kaufmann, A.M., Albers, A.E.: Immunotherapeutics for head and neck squamous cell carcinoma stem cells. HNO. 68, 94-99 (2020).

Qian, X., Leonard, F., Wenhao, Y., Sudhoff, Holger, Hoffmann, T. K., Ferrone, S., Kaufmann, A. M., and Albers, A. E. “Immunotherapeutics for head and neck squamous cell carcinoma stem cells”. HNO 68.2 (2020): 94-99.

Daten bereitgestellt von European Bioinformatics Institute (EBI)